INTERNATIONAL PATENT: DIRECT BIOLOGICS, LLC FILES APPLICATION FOR "EXTRACELLULAR VESICLE COMPOSITION FOR USE IN THE TREATMENT OF LONG COVID"

GENEVA, May 19 -- DIRECT BIOLOGICS, LLC (5301 Southwest ParkwayBldg. 1, Suite 415Austin, Texas 78735) filed a patent application (PCT/US2024/054785) for "EXTRACELLULAR VESICLE COMPOSITION FOR USE IN THE TREATMENT OF LONG COVID" on Nov 06, 2024. With publication no. WO/2025/101653, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PETTINE, Kenneth Allen (c/o DIRECT BIOLOGICS, LLC5301 Southwest ParkwayBldg. 1, Suite 415Austin, Texas 78735), MOSELEY, Timothy Alexander (c/o DIRECT BIOLOGICS, LLC5301 Southwest ParkwayBldg. 1, Su...